8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Data-driven Derivation and Validation of Novel Phenotypes for Acute Kidney Transplant Rejection using Semi-supervised Clustering

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance Statement

          The current Banff classification of kidney transplant rejection is on the basis of complex and discretionary combinations of histologic scores. As a purely empiric classification, it was not primarily developed to reflect clinically meaningful outcomes such as graft failure, and allows ambiguous phenotypes to overlap. This paper describes the use of data-driven clustering methods to produce a phenotypic reclassification of kidney transplant rejection that is both histologically and clinically relevant. Six novel cluster phenotypes are validated on external data. Each of these new phenotypes is significantly associated with graft failure and overcomes the current limitations of intermediate and mixed phenotypes. The data-driven phenotypic reclassification of kidney transplant rejection is a proof of concept, opening future research directions.

          Visual Abstract

          Abstract

          Background

          Over the past decades, an international group of experts iteratively developed a consensus classification of kidney transplant rejection phenotypes, known as the Banff classification. Data-driven clustering of kidney transplant histologic data could simplify the complex and discretionary rules of the Banff classification, while improving the association with graft failure.

          Methods

          The data consisted of a training set of 3510 kidney-transplant biopsies from an observational cohort of 936 recipients. Independent validation of the results was performed on an external set of 3835 biopsies from 1989 patients. On the basis of acute histologic lesion scores and the presence of donor-specific HLA antibodies, stable clustering was achieved on the basis of a consensus of 400 different clustering partitions. Additional information on kidney-transplant failure was introduced with a weighted Euclidean distance.

          Results

          Based on the proportion of ambiguous clustering, six clinically meaningful cluster phenotypes were identified. There was significant overlap with the existing Banff classification (adjusted rand index, 0.48). However, the data-driven approach eliminated intermediate and mixed phenotypes and created acute rejection clusters that are each significantly associated with graft failure. Finally, a novel visualization tool presents disease phenotypes and severity in a continuous manner, as a complement to the discrete clusters.

          Conclusions

          A semisupervised clustering approach for the identification of clinically meaningful novel phenotypes of kidney transplant rejection has been developed and validated. The approach has the potential to offer a more quantitative evaluation of rejection subtypes and severity, especially in situations in which the current histologic categorization is ambiguous.

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative endpoints for next‐generation clinical trials

          The kidney sessions of the 2017 Banff Conference focused on 2 areas: clinical implications of inflammation in areas of interstitial fibrosis and tubular atrophy (i‐IFTA) and its relationship to T cell–mediated rejection (TCMR), and the continued evolution of molecular diagnostics, particularly in the diagnosis of antibody‐mediated rejection (ABMR). In confirmation of previous studies, it was independently demonstrated by 2 groups that i‐IFTA is associated with reduced graft survival. Furthermore, these groups presented that i‐IFTA, particularly when involving >25% of sclerotic cortex in association with tubulitis, is often a sequela of acute TCMR in association with underimmunosuppression. The classification was thus revised to include moderate i‐IFTA plus moderate or severe tubulitis as diagnostic of chronic active TCMR. Other studies demonstrated that certain molecular classifiers improve diagnosis of ABMR beyond what is possible with histology, C4d, and detection of donor‐specific antibodies (DSAs) and that both C4d and validated molecular assays can serve as potential alternatives and/or complements to DSAs in the diagnosis of ABMR. The Banff ABMR criteria are thus updated to include these alternatives. Finally, the present report paves the way for the Banff scheme to be part of an integrative approach for defining surrogate endpoints in next‐generation clinical trials.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology

            The XIII Banff meeting, held in conjunction the Canadian Society of Transplantation in Vancouver, Canada, reviewed the clinical impact of updates of C4d‐negative antibody‐mediated rejection (ABMR) from the 2013 meeting, reports from active Banff Working Groups, the relationships of donor‐specific antibody tests (anti‐HLA and non‐HLA) with transplant histopathology, and questions of molecular transplant diagnostics. The use of transcriptome gene sets, their resultant diagnostic classifiers, or common key genes to supplement the diagnosis and classification of rejection requires further consensus agreement and validation in biopsies. Newly introduced concepts include the i‐IFTA score, comprising inflammation within areas of fibrosis and atrophy and acceptance of transplant arteriolopathy within the descriptions of chronic active T cell–mediated rejection (TCMR) or chronic ABMR. The pattern of mixed TCMR and ABMR was increasingly recognized. This report also includes improved definitions of TCMR and ABMR in pancreas transplants with specification of vascular lesions and prospects for defining a vascularized composite allograft rejection classification. The goal of the Banff process is ongoing integration of advances in histologic, serologic, and molecular diagnostic techniques to produce a consensus‐based reporting system that offers precise composite scores, accurate routine diagnostics, and applicability to next‐generation clinical trials.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology

              Abstract The Banff Classification of Allograft Pathology is an international consensus classification for the reporting of biopsies from solid organ transplants. Since its initial conception in 1991 for renal transplants, it has undergone review every 2 years, with attendant updated publications. The rapid expansion of knowledge in the field has led to numerous revisions of the classification. The resultant dispersal of relevant content makes it difficult for novices and experienced pathologists to faithfully apply the classification in routine diagnostic work and in clinical trials. This review shall provide a complete and simple illustrated reference guide of the Banff Classification of Kidney Allograft Pathology based on all publications including the 2017 update. It is intended as a concise desktop reference for pathologists and clinicians, providing definitions, Banff Lesion Scores and Banff Diagnostic Categories. An online website reference guide hosted by the Banff Foundation for Allograft Pathology (www.banfffoundation.org) is being developed, which will be updated with future refinement of the Banff Classification from 2019 onward.
                Bookmark

                Author and article information

                Journal
                J Am Soc Nephrol
                J Am Soc Nephrol
                jnephrol
                jnephrol
                ASN
                Journal of the American Society of Nephrology : JASN
                American Society of Nephrology
                1046-6673
                1533-3450
                03 May 2021
                03 May 2021
                : 32
                : 5
                : 1084-1096
                Affiliations
                [1 ]Department of Electrical Engineering, Stadius Center for Dynamical Systems, Signal Processing and Data Analytics, KU Leuven, Leuven, Belgium
                [2 ]Université de Paris, National Institutes of Health and Medical Research, Paris Translational Research Centre for Organ Transplantation, Paris, France
                [3 ]Kidney Transplant Department, Necker Hospital, Assistance Publique Hôpitaux de Paris, Paris, France
                [4 ]French National Institutes of Health and Medical Research, Lyon, France
                [5 ]Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon, Edouard Herriot Hospital, Lyon, France
                [6 ]Department of Imaging and Pathology, University Hospitals Leuven, Leuven, Belgium
                [7 ]Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium
                [8 ]Histocompatibility and Immunogenetics Laboratory, Belgian Red Cross—Flanders, Mechelen, Belgium
                [9 ]Department of Nephrology and Kidney Transplantation, University Hospitals Leuven, Leuven, Belgium
                [10 ]Department of Pathology, Hospices Civils de Lyon, Bron, France
                [11 ]French National Blood Service, Décines-Charpieu, France
                [12 ]Department of Development and Regeneration, University Hospitals Leuven, KU Leuven, Leuven, Belgium
                Author notes
                Correspondence: Prof. Maarten Naesens, Department of Microbiology, Immunology and Transplantation, KU Leuven, University of Leuven, Belgium. Email: maarten.naesens@ 123456kuleuven.be
                Author information
                https://orcid.org/0000-0002-3450-0033
                https://orcid.org/0000-0002-6196-4669
                https://orcid.org/0000-0001-6284-3757
                https://orcid.org/0000-0001-9796-9157
                https://orcid.org/0000-0003-2235-9842
                https://orcid.org/0000-0003-3388-7747
                https://orcid.org/0000-0002-5625-0792
                Article
                2020101418
                10.1681/ASN.2020101418
                8259675
                33687976
                6d722e13-b314-4c89-b201-1152d0cb6696
                Copyright © 2021 by the American Society of Nephrology

                This is an Open Access article: American Society of Nephrology

                History
                : 06 October 2020
                : 04 January 2021
                Page count
                Figures: 4, Tables: 3, Equations: 0, References: 28, Pages: 13
                Funding
                Funded by: The Research Foundation Flanders https://doi.org/10.13039/501100003130
                Award ID: IWT.150199
                Funded by: KU Leuven https://doi.org/10.13039/501100004040
                Award ID: C32/17/049
                Award ID: 1844019N
                Award ID: 1842919N
                Award ID: 1S93918N
                Award ID: 1143919N
                Award ID: 1196119N
                Funded by: Agence Nationale pour la Recherche https://doi.org/10.13039/501100001665
                Award ID: ANR-16-CE17-0007-01
                Funded by: Fondation pour la Recherche médicale https://doi.org/10.13039/501100002915
                Award ID: PME20180639518
                Funded by: KU Leuven
                Award ID: C16/15/059
                Award ID: C32/16/013
                Award ID: C24/18/022
                Funded by: Industrial Research Fund
                Award ID: Fellowship 13-0260
                Award ID: FWO
                Award ID: 30468160
                Award ID: I013218N
                Funded by: Flemish Government https://doi.org/10.13039/501100011878
                Award ID: AI Research Program
                Funded by: VLAIO https://doi.org/10.13039/100012331
                Award ID: COT.2018.018
                Funded by: Industrial Projects
                Award ID: HBC.2018.0405
                Funded by: European Research Council https://doi.org/10.13039/100010663
                Award ID: 885682
                Funded by: Institut National de la Santé et de la Recherche Médicale https://doi.org/10.13039/501100001677
                Award ID: ATIP Avenir
                Funded by: Fondation Bettencourt Schueller https://doi.org/10.13039/501100007492
                Funded by: Fondation pour la Recherche Médicale
                Categories
                Basic Research
                Custom metadata
                May 2021

                Nephrology
                acute allograft rejection,kidney biopsy,transplant pathology,transplant outcomes,kidney transplantation

                Comments

                Comment on this article